Citation: Elisa Isopi, Giuseppe Legname. Pin1 and neurodegeneration: a new player for prion disorders?[J]. AIMS Molecular Science, 2015, 2(3): 311-323. doi: 10.3934/molsci.2015.3.311
| [1] | Xianmin Geng, Shengli Zhou, Jiashan Tang, Cong Yang . A sufficient condition for classified networks to possess complex network features. Networks and Heterogeneous Media, 2012, 7(1): 59-69. doi: 10.3934/nhm.2012.7.59 |
| [2] | Simone Göttlich, Stephan Martin, Thorsten Sickenberger . Time-continuous production networks with random breakdowns. Networks and Heterogeneous Media, 2011, 6(4): 695-714. doi: 10.3934/nhm.2011.6.695 |
| [3] | Wenlian Lu, Fatihcan M. Atay, Jürgen Jost . Consensus and synchronization in discrete-time networks of multi-agents with stochastically switching topologies and time delays. Networks and Heterogeneous Media, 2011, 6(2): 329-349. doi: 10.3934/nhm.2011.6.329 |
| [4] | Alessia Marigo, Benedetto Piccoli . A model for biological dynamic networks. Networks and Heterogeneous Media, 2011, 6(4): 647-663. doi: 10.3934/nhm.2011.6.647 |
| [5] | Mirela Domijan, Markus Kirkilionis . Graph theory and qualitative analysis of reaction networks. Networks and Heterogeneous Media, 2008, 3(2): 295-322. doi: 10.3934/nhm.2008.3.295 |
| [6] | M. D. König, Stefano Battiston, M. Napoletano, F. Schweitzer . On algebraic graph theory and the dynamics of innovation networks. Networks and Heterogeneous Media, 2008, 3(2): 201-219. doi: 10.3934/nhm.2008.3.201 |
| [7] | Michael Damron, C. L. Winter . A non-Markovian model of rill erosion. Networks and Heterogeneous Media, 2009, 4(4): 731-753. doi: 10.3934/nhm.2009.4.731 |
| [8] | Regino Criado, Julio Flores, Alejandro J. García del Amo, Miguel Romance . Structural properties of the line-graphs associated to directed networks. Networks and Heterogeneous Media, 2012, 7(3): 373-384. doi: 10.3934/nhm.2012.7.373 |
| [9] | Roberto Serra, Marco Villani, Alex Graudenzi, Annamaria Colacci, Stuart A. Kauffman . The simulation of gene knock-out in scale-free random Boolean models of genetic networks. Networks and Heterogeneous Media, 2008, 3(2): 333-343. doi: 10.3934/nhm.2008.3.333 |
| [10] | Martin Gugat, Rüdiger Schultz, Michael Schuster . Convexity and starshapedness of feasible sets in stationary flow networks. Networks and Heterogeneous Media, 2020, 15(2): 171-195. doi: 10.3934/nhm.2020008 |
The special issue webpage is avaiable at: https://aimspress.com/mbe/article/5630/special-articles.
An outbreak of atypical pneumonia caused by a novel coronavirus was first identified in Wuhan, China in December 2019. The causative agent was initially called 2019 novel coronavirus (2019-nCoV), later renamed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the formal name for the associated disease given by the World Health Organization (WHO) is Coronavirus Disease 2019 (COVID-19). The virus swiftly spread to all areas of China and other countries. The WHO declared the coronavirus outbreak a public health emergency of international concern (PHEIC) on January 30, 2020. Mathematical models play an increasingly important role in forecasting transmission potential, optimizing control strategies, understanding the progression of infections within hosts, managing vaccine distribution and so on. These contributions have been recognized by many public health agencies like the WHO and the U.S. CDC.
To serve the needs of the fight against the COVID-19 pandemic, it is critical to accelerate the publication of modeling studies on COVID-19. With the support of Mathematical Biosciences and Engineering (MBE), we initiated a special issue entitled "Modeling the Biological, Epidemiological, Immunological, Molecular, Virological Aspects of COVID-19" on January 31, 2020. By the deadline of September 1, 2020, a total of 118 formal submissions from researchers across 40 countries around the world had been received, among which 38 papers were finally accepted for publication after peer review. Among the accepted contributions, the average times from submission to acceptance, and from acceptance to publication are 43 days and 9 days, respectively. The special issue covers a wide range of topics using different modeling approaches and different data sources.
The works of Zhou et al. (doi: 10.3934/mbe.2020147), Yang and Wang (10.3934/mbe.2020148), Chang et al. (10.3934/mbe.2020178), Feng et al. (10.3934/mbe.2020204), Aldila et al. (10.3934/mbe.2020335), Wang (10.3934/mbe.2020380), and Johnston and Pell (10.3934/mbe.2020401) investigate the role of behavior change or social distancing driven by media coverage or governmental action in curtailing the spread of COVID-19. The information propagation about COVID-19 in Chinese social media during the early phase of the epidemic is modeled and analyzed by Yin et al. (10.3934/mbe.2020146). Some studies focus on evaluating the impact of non-pharmaceutical interventions such as quarantine, isolation, personal hygiene, travel restriction and city lockdown on curbing the disease spread (Dai et al., 10.3934/mbe.2020152; Tian et al., 10.3934/mbe.2020158; Saldaña et al., 10.3934/mbe.2020231; Bugalia et al., 10.3934/mbe.2020318; Yousif and Ali, 10.3934/mbe.2020412; Srivastav et al., 10.3934/mbe.2021010). Some concentrate on assessing the importance of the timing to relax or lift mobility restrictions (Santana-Cibrian et al., 10.3934/mbe.2020330; Iboi et al., 10.3934/mbe.2020369). Some authors estimate key epidemiological parameters including basic reproduction number and effective reproduction number, peak time and peak size, final size, serial interval (Liu et al., 10.3934/mbe.2020172; Wang et al., 10.3934/mbe.2020173; Zhao, 10.3934/mbe.2020198; Feng et al., 10.3934/mbe.2020205). Besides human-to-human transmission, Yang and Wang (10.3934/mbe.2020148), Rong et al. (10.3934/mbe.2020149), Saldaña et al. (10.3934/mbe.2020231), and Zhong and Wang (10.3934/mbe.2020357) also take environment-to-human transmission into consideration. Some address the effect of delay in diagnosis (Rong et al., 10.3934/mbe.2020149), lack of medical resources (Wang et al., 10.3934/mbe.2020165), difference in interventions (Xia et al., 10.3934/mbe.2020274), incoming travelers (Deeb and Jalloul, 10.3934/mbe.2020302), superspreading events (Santana-Cibrian et al., 10.3934/mbe.2020330), nosocomial infections (Martos et al., 10.3934/mbe.2020410), transient behavior after mass vaccination (Akhavan Kharazian and Magpantay, 10.3934/mbe.2021019). Two models are proposed to describe SARS-CoV-2 dynamics in infected hosts (Li et al., 10.3934/mbe.2020159; Hattaf and Yousfi, 10.3934/mbe.2020288).
Most studies are based on deterministic ordinary differential equation type models whereas partial differential equation models (Zhu and Zhu, 10.3934/mbe.2020174; Wang and Yamamoto, 10.3934/mbe.2020266), complex network model (Yang et al., 10.3934/mbe.2020248), stochastic models (He et al., 10.3934/mbe.2020153; Olabode et al., 10.3934/mbe.2021050), discrete models (He et al., 10.3934/mbe.2020153, Li et al., 10.3934/mbe.2020208), individual-based model (Martos et al., 10.3934/mbe.2020410), and statistical models (Zhao, 10.3934/mbe.2020198; Nie et al., 10.3934/mbe.2020265; Xia et al., 10.3934/mbe.2020274; Chowdhury et al., 10.3934/mbe.2020323) are developed and analyzed as well. Early studies mainly deal with COVID-19 case data from China, and later studies fit models to data from various countries and regions including the United Kingdom (Feng et al., 10.3934/mbe.2020204), South Korea (Feng et al., 10.3934/mbe.2020205; Xia et al., 10.3934/mbe.2020274), Mexico (Saldaña et al., 10.3934/mbe.2020231; Santana-Cibrian et al., 10.3934/mbe.2020330), the United States (Wang and Yamamoto, 10.3934/mbe.2020266), Lebanon (Deeb and Jalloul, 10.3934/mbe.2020302), India (Bugalia et al., 10.3934/mbe.2020318; Srivastav et al., 10.3934/mbe.2021010), Indonesia (Aldila et al., 10.3934/mbe.2020335), Nigeria (Iboi et al., 10.3934/mbe.2020369), Canada (Wang, 10.3934/mbe.2020380), Saudi Arabia (Yousif and Ali, 10.3934/mbe.2020412) and so on. Mobile terminal positioning data (Nie et al., 10.3934/mbe.2020265) and Google community mobility data (Wang and Yamamoto, 10.3934/mbe.2020266) have also been used. In addition, Costris-Vas et al. (10.3934/mbe.2020383) write a survey paper on evaluating the accuracy of various models from recent pandemics.
With the broad spectrum of topics, we believe that these 38 peer-reviewed papers could represent a significant contribution of mathematical modeling in the fight against COVID-19. In fact, they have already received considerable attention in the field. For example, the paper by Yang and Wang (10.3934/mbe.2020148) is ranked the first most read paper in MBE with 2765 article views, 4465 PDF downloads and 54 citations. We hope the readers of this special issue will find helpful information for their own research and decision-making. So far, the ongoing COVID-19 pandemic has resulted in more than 85.62 million cases including 1.85 million deaths (data source: https://coronavirus.jhu.edu/map.html). With the joint efforts of health-care workers, vaccine developers, epidemiologists, modelers, the public and others, we look forward to returning to normal life in the near future.
The guest editors sincerely appreciate all authors for their valuable contributions and all referees for their constructive feedback. The guest editors thank the Editor-in-Chief, Professor Yang Kuang, and Editor-in-Chief of Mathematics section, Professor Shigui Ruan, for their kind invitation, and the Editorial Assistants for their patience and help, and the publisher AIMS for the generous support. Finally, DG acknowledge the financial support from the NSF of China (12071300), and NSF of Shanghai (20ZR1440600 and 20JC1413800). DH was partially supported by an Alibaba (China) Co. Ltd. Collaborative Research grant.
| [1] |
Lu KP, Hanes SD, Hunter T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547. doi: 10.1038/380544a0
|
| [2] |
Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8: 904-916. doi: 10.1038/nrm2261
|
| [3] |
Liou Y-C, Sun A, Ryo A, et al. (2003) Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424: 556-561. doi: 10.1038/nature01832
|
| [4] | Rudrabhatla P (2014) Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases. J Alzheimers Dis 41: 671-684. |
| [5] |
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. doi: 10.1126/science.1072994
|
| [6] |
Anderson JP, Walker DE, Goldstein JM, et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281: 29739-29752. doi: 10.1074/jbc.M600933200
|
| [7] |
Kardos J, Kiss B, Micsonai A, et al. (2015) Phosphorylation as conformational switch from the native to amyloid state: trp-cage as a protein aggregation model. J Phys Chem B 119: 2946-2955. doi: 10.1021/jp5124234
|
| [8] |
Grison A, Mantovani F, Comel A, et al. (2011) Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. P Natl Acad Sci U S A 108: 17979-17984. doi: 10.1073/pnas.1106198108
|
| [9] | Rudrabhatla P, Pant HC (2010) Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration. J Alzheimers Dis 19: 389-403. |
| [10] | Driver JA, Zhou XZ, Lu KP (2014) Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease. Discov Med 17: 93-99. |
| [11] |
Nakamura K, Greenwood A, Binder L, et al. (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149: 232-244. doi: 10.1016/j.cell.2012.02.016
|
| [12] |
Giannopoulos PN, Robertson C, Jodoin J, et al. (2009) Phosphorylation of prion protein at serine 43 induces prion protein conformational change. J Neurosci 29: 8743-8751. doi: 10.1523/JNEUROSCI.2294-09.2009
|
| [13] |
Liou Y-C, Zhou XZ, Lu KP (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 36: 501-514. doi: 10.1016/j.tibs.2011.07.001
|
| [14] |
Bayer E, Goettsch S, Mueller JW, et al. (2003) Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J Biol Chem 278: 26183-26193. doi: 10.1074/jbc.M300721200
|
| [15] |
Matena A, Sinnen C, van den Boom J, et al. (2013) Transient domain interactions enhance the affinity of the mitotic regulator Pin1 toward phosphorylated peptide ligands. Structure 21: 1769-1777. doi: 10.1016/j.str.2013.07.016
|
| [16] |
Vöhringer-Martinez E, Verstraelen T, Ayers PW (2014) The influence of Ser-154, Cys-113, and the phosphorylated threonine residue on the catalytic reaction mechanism of Pin1. J Phys Chem B 118: 9871-9880. doi: 10.1021/jp505638w
|
| [17] |
Pastorino L, Sun A, Lu P-J, et al. (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440: 528-534. doi: 10.1038/nature04543
|
| [18] |
Zita MM, Marchionni I, Bottos E, et al. (2007) Post-phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function. EMBO J 26: 1761-1771. doi: 10.1038/sj.emboj.7601625
|
| [19] |
Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296: 1991-1995. doi: 10.1126/science.1067122
|
| [20] |
Kim S, Nollen EA, Kitagawa K, et al. (2002) Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4: 826-831. doi: 10.1038/ncb863
|
| [21] | Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65: 184-189. |
| [22] | Tenreiro S, Eckermann K, Outeiro TF (2014) Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 7: 42. |
| [23] | Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11: 301-307. |
| [24] |
Brettschneider J, Del Tredici K, Lee VM, et al. (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16: 109-120. doi: 10.1038/nrn3887
|
| [25] |
LaFerla FM (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38: 993-995. doi: 10.1042/BST0380993
|
| [26] |
Iqbal K, Grundke-Iqbal I (2010) Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement 6: 420-424. doi: 10.1016/j.jalz.2010.04.006
|
| [27] |
Rudrabhatla P, Jaffe H, Pant HC (2011) Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs. FASEB J 25: 3896-3905. doi: 10.1096/fj.11-181297
|
| [28] |
Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148: 1204-1222. doi: 10.1016/j.cell.2012.02.040
|
| [29] |
Cancino GI, Miller FD, Kaplan DR (2013) p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease. Neurobiol Aging 34: 387-399. doi: 10.1016/j.neurobiolaging.2012.04.010
|
| [30] |
Sultana R, Boyd-Kimball D, Poon HF, et al. (2006) Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 27: 918-925. doi: 10.1016/j.neurobiolaging.2005.05.005
|
| [31] |
Chen C-H, Li W, Sultana R, et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76: 13-23. doi: 10.1016/j.nbd.2014.12.027
|
| [32] |
Innes BT, Sowole MA, Gyenis L, et al. (2015) Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1. Biochim Biophys Acta 1852: 905-912. doi: 10.1016/j.bbadis.2014.12.025
|
| [33] |
Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, et al. (2005) Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 1739: 216-223. doi: 10.1016/j.bbadis.2004.08.014
|
| [34] |
Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4: 13. doi: 10.1186/1750-1326-4-13
|
| [35] |
Kimura T, Tsutsumi K, Taoka M, et al. (2013) Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J Biol Chem 288: 7968-7977. doi: 10.1074/jbc.M112.433326
|
| [36] |
Yotsumoto K, Saito T, Asada A, et al. (2009) Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau. J Biol Chem 284: 16840-16847. doi: 10.1074/jbc.M109.003277
|
| [37] |
Smet C, Sambo A-V, Wieruszeski J-M, et al. (2004) The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. Biochemistry 43: 2032-2040. doi: 10.1021/bi035479x
|
| [38] |
Wang J-Z, Zhang Y (2015) Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease. J Neurol Sci 348: 253-255. doi: 10.1016/j.jns.2014.11.011
|
| [39] |
Yuan A, Sasaki T, Rao MV, et al. (2009) Neurofilaments form a highly stable stationary cytoskeleton after reaching a critical level in axons. J Neurosci 29: 11316-11329. doi: 10.1523/JNEUROSCI.1942-09.2009
|
| [40] |
Nixon RA, Shea TB (1992) Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil Cytoskeleton 22: 81-91. doi: 10.1002/cm.970220202
|
| [41] | Giasson BI, Mushynski WE (1997) Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. J Neurosci 17: 9466-9472. |
| [42] | Haass C, Kaether C, Thinakaran G, et al. (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2: a006270. |
| [43] | Pastorino L, Ma SL, Balastik M, et al. (2012) Alzheimer's disease-related loss of Pin1 function influences the intracellular localization and the processing of AβPP. J Alzheimers Dis 30: 277-297. |
| [44] |
Lee M-S, Kao S-C, Lemere CA, et al. (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163: 83-95. doi: 10.1083/jcb.200301115
|
| [45] |
Ma SL, Pastorino L, Zhou XZ, et al. (2012) Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β (GSK3β) activity: novel mechanism for Pin1 to protect against Alzheimer disease. J Biol Chem 287: 6969-6973. doi: 10.1074/jbc.C111.298596
|
| [46] |
Cisbani G, Cicchetti F (2012) An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis 3: e382. doi: 10.1038/cddis.2012.121
|
| [47] |
Ross CA, Aylward EH, Wild EJ, et al. (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10: 204-216. doi: 10.1038/nrneurol.2014.24
|
| [48] |
Bertoni A, Giuliano P, Galgani M, et al. (2011) Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins. J Biol Chem 286: 4727-4741. doi: 10.1074/jbc.M110.156521
|
| [49] |
Bae B-I, Xu H, Igarashi S, et al. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47: 29-41. doi: 10.1016/j.neuron.2005.06.005
|
| [50] | Sorrentino G, Comel A, Mantovani F, et al. (2014) Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration. Mitochondrion 19 Pt A: 88-96. |
| [51] | Mantovani F, Zannini A, Rustighi A, et al. (2015) Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships. Biochim Biophys Acta [in press]. |
| [52] |
Sorrentino G, Mioni M, Giorgi C, et al. (2013) The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. Cell Death Differ 20: 198-208. doi: 10.1038/cdd.2012.112
|
| [53] | Beitz JM (2014) Parkinson's disease: a review. Front Biosci 6: 65-74. |
| [54] |
Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909. doi: 10.1016/S0896-6273(03)00568-3
|
| [55] | Fujiwara H, Hasegawa M, Dohmae N, et al. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4: 160-164. |
| [56] | Sato H, Kato T, Arawaka S (2013) The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models. Rev Neurosci 24: 115-123. |
| [57] |
Ryo A, Togo T, Nakai T, et al. (2006) Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem 281: 4117-4125. doi: 10.1074/jbc.M507026200
|
| [58] |
Ghosh A, Saminathan H, Kanthasamy A, et al. (2013) The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem 288: 21955-21971. doi: 10.1074/jbc.M112.444224
|
| [59] |
Lee S-J, Kim D-C, Choi B-H, et al. (2006) Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death. J Biol Chem 281: 2215-2224. doi: 10.1074/jbc.M509509200
|
| [60] |
Martin LJ, Pan Y, Price AC, et al. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26: 41-50. doi: 10.1523/JNEUROSCI.4308-05.2006
|
| [61] |
Mogi M, Kondo T, Mizuno Y, et al. (2007) p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett 414: 94-97. doi: 10.1016/j.neulet.2006.12.003
|
| [62] |
Prusiner SB (1988) Molecular structure, biology, and genetics of prions. Adv Virus Res 35: 83-136. doi: 10.1016/S0065-3527(08)60709-5
|
| [63] |
Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515-1522. doi: 10.1126/science.1675487
|
| [64] |
Prusiner SB (1994) Molecular biology and genetics of prion diseases. Philos Trans R Soc Lond B Biol Sci 343: 447-463. doi: 10.1098/rstb.1994.0043
|
| [65] |
Prusiner SB (2001) Shattuck lecture--neurodegenerative diseases and prions. New Engl J Med 344: 1516-1526. doi: 10.1056/NEJM200105173442006
|
| [66] |
Zhou Z, Xiao G (2013) Conformational conversion of prion protein in prion diseases. Acta Biochim Biophys Sin 45: 465-476. doi: 10.1093/abbs/gmt027
|
| [67] |
Negro A, Meggio F, Bertoli A, et al. (2000) Susceptibility of the prion protein to enzymic phosphorylation. Biochem Biophys Res Commun 271: 337-341. doi: 10.1006/bbrc.2000.2628
|
| [68] |
Wang G-R, Shi S, Gao C, et al. (2010) Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases. BMC Infect Dis 10: 86. doi: 10.1186/1471-2334-10-86
|
| [69] |
Schmitz M, Lüllmann K, Zafar S, et al. (2014) Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Neurobiol Aging 35: 1177-1188. doi: 10.1016/j.neurobiolaging.2013.11.010
|
| [70] |
Rouget R, Sharma G, LeBlanc AC (2015) Cyclin-dependent Kinase 5 Phosphorylation of Familial Prion Protein Mutants Exacerbates Conversion into Amyloid Structure. J Biol Chem 290: 5759-5771. doi: 10.1074/jbc.M114.630699
|
| [71] |
Trevitt CR, Hosszu LLP, Batchelor M, et al. (2014) N-terminal domain of prion protein directs its oligomeric association. J Biol Chem 289: 25497-25508. doi: 10.1074/jbc.M114.566588
|
| [72] |
Supattapone S, Muramoto T, Legname G, et al. (2001) Identification of two prion protein regions that modify scrapie incubation time. J Virol 75: 1408-1413. doi: 10.1128/JVI.75.3.1408-1413.2001
|
| [73] |
Frankenfield KN, Powers ET, Kelly JW (2005) Influence of the N-terminal domain on the aggregation properties of the prion protein. Protein Sci 14: 2154-2166. doi: 10.1110/ps.051434005
|
| [74] |
Uchida T, Takamiya M, Takahashi M, et al. (2003) Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 10: 15-24. doi: 10.1016/S1074-5521(02)00310-1
|
| 1. | Qu Qinqin, Gao Chao, Qiu Lei, Liu Yue, 2019, Congestion control strategy for power scale-free communication network by link addition, 978-1-7281-0510-9, 1714, 10.1109/ICEMI46757.2019.9101412 |
Figures(1)
Elisa Isopi, Giuseppe Legname. Pin1 and neurodegeneration: a new player for prion disorders?[J]. AIMS Molecular Science, 2015, 2(3): 311-323. doi: 10.3934/molsci.2015.3.311
DownLoad: